Literature DB >> 1419956

T cell receptor alpha-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257-264 determinant.

F R Carbone1, S J Sterry, J Butler, S Rodda, M W Moore.   

Abstract

Ovalbumin-specific, Kb-restricted T cells recognize the minimal fully active synthetic peptide ovalbumin (OVA)257-264. This sequence coincides with the eight residue, allele-specific peptide binding motif previously predicted from direct sequencing of naturally occurring Kb-associated peptides (Falk, K., Rotzscke, O., Stevanovic, S., Jung, G., and Rammensee, H.-G., Nature 351:290, 1990). T cell recognition of a panel of analogs with single residue substitutions between the two putative Kb anchor residues at OVA261 and OVA264 suggested that at least one residue, Glu at position 262, is involved in TCR interaction. OVA-specific cytotoxic T lymphocytes (CTL) derived from TCR beta-chain transgenic mice, where the beta-chain originates from an OVA-specific, Kb-restricted CTL B3, showed that differences in TCR alpha-chain pairing determined the specificity for OVA residue 262. These data support the notion that residue 262 of the OVA T cell determinant, corresponding to position 6 within the Kb-binding motif, represents a contact site for TCR. This residue interacts directly with the TCR alpha-chain or with a site on the TCR beta-chain whose conformation is affected by TCR alpha-chain pairing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419956     DOI: 10.1093/intimm/4.8.861

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  21 in total

1.  Expression and function of synaptotagmin VII in CTLs.

Authors:  Kimberly T Fowler; Norma W Andrews; James W Huleatt
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

2.  Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes.

Authors:  Lee Kim Swee; Carla P Guimaraes; Sharvan Sehrawat; Eric Spooner; M Inmaculada Barrasa; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

3.  Identification and characterization of thymus LIM protein: targeted disruption reduces thymus cellularity.

Authors:  J Kirchner; K A Forbush; M J Bevan
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.

Authors:  Deanna N Edwards; Verra M Ngwa; Ariel L Raybuck; Shan Wang; Yoonha Hwang; Laura C Kim; Sung Hoon Cho; Yeeun Paik; Qingfei Wang; Siyuan Zhang; H Charles Manning; Jeffrey C Rathmell; Rebecca S Cook; Mark R Boothby; Jin Chen
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

5.  Modulation of TCRβ surface expression during TCR revision.

Authors:  Kalynn B Simmons; Maramawit Wubeshet; Kristina T Ames; Catherine J McMahan; J Scott Hale; Pamela J Fink
Journal:  Cell Immunol       Date:  2011-11-15       Impact factor: 4.868

6.  Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.

Authors:  C Justin Van De Wiele; James G Vaughn; Michael R Blackburn; Catherine A Ledent; Marlene Jacobson; Hong Jiang; Linda F Thompson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

7.  Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?

Authors:  Nadia Anikeeva; Tatiana Mareeva; Wei Liu; Yuri Sykulev
Journal:  Clin Immunol       Date:  2008-10-08       Impact factor: 3.969

8.  Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells.

Authors:  M R Jackson; E S Song; Y Yang; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells.

Authors:  G J Schoenhals; R M Krishna; A G Grandea; T Spies; P A Peterson; Y Yang; K Früh
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.

Authors:  Africa Wallace; Veena Kapoor; Jing Sun; Paul Mrass; Wolfgang Weninger; Daniel F Heitjan; Carl June; Larry R Kaiser; Leona E Ling; Steven M Albelda
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.